If they just failed absolutely. I’m talking like 1 percent of all 3 big drugs coming up, AND assuming the 5.1B drug market drops to 2B… they will STILL more than double revenues to $80M or more.
That’s if they do a totally horrific job at grabbing market share in all 3 new drugs coming up - all 3 of which are “high profile” drugs, some of which are in shortage.